Furthermore, the canine GL-1 cell line was found to be sensitive to the FLT3 inhibitor lestaurtinib, similar to the human leukemia cell line MV4-11 carrying a comparable FLT3 mutation [51]. The gene discussed is FLT3; the disease is leukemia.